For the mature and hypermature NK subsets, a clearly higher expression of KIR (similar to CD159a) was observed in AML compared to NBM, providing further evidence for an immune response that is hindered from acting against malignant cells. The gene discussed is KLRC1; the disease is acute myeloid leukemia.